You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Mendus Q1: CEO Interview
Immunotherapy remains a game-changer in the rapidly evolving landscape of cancer treatment. Leading this wave of innovation is Mendus, which released its Q1 report yesterday (6/5). To discuss the report and key developments from the quarter, we spoke with CEO Erik Manting in an exclusive interview.
Watch the Q1 presentation from Mendus here.
Följ oss på:
Du är hjärtligt välkommen att ansluta dig till vår kostnadsfria community och delta i heta aktiediskussioner på forumet